CASI Pharmaceuticals, Inc (DE) Annual Return On Assets in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Return On Assets history and growth rate from 2012 to 2022.
  • CASI Pharmaceuticals, Inc (DE) Return On Assets for the quarter ending December 31, 2022 was -34.7 %, a 34.3% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Return On Assets for 2022 was -34.7 %, a 34.3% decline from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Return On Assets for 2021 was -25.9 %, a 39.4% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Return On Assets for 2020 was -42.6 %, a 6.47% decline from 2019.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -34.7 -8.87 -34.3% Jan 1, 2022 Dec 31, 2022
2021 -25.9 +16.8 +39.4% Jan 1, 2021 Dec 31, 2021
2020 -42.6 -2.59 -6.47% Jan 1, 2020 Dec 31, 2020
2019 -40 -12.1 -43.1% Jan 1, 2019 Dec 31, 2019
2018 -28 +8.48 +23.3% Jan 1, 2018 Dec 31, 2018
2017 -36.5 +7.52 +17.1% Jan 1, 2017 Dec 31, 2017
2016 -44 +47 +51.6% Jan 1, 2016 Dec 31, 2016
2015 -91 +111 +55% Jan 1, 2015 Dec 31, 2015
2014 -202 -168 -497% Jan 1, 2014 Dec 31, 2014
2013 -33.9 +111 +76.5% Jan 1, 2013 Dec 31, 2013
2012 -144 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.